FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

929360061000036106: Medicinal product reference set (foundation metadata concept)


Status: current, Primitive. Date: 31-Mar 2011. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
3288191000168117 MP (medicinal product) reference set en Synonym Active Case sensitive Australian Medicines Terminology module
965507111000036114 Medicinal product reference set en Synonym Active Case sensitive Australian Medicines Terminology module
965507121000036119 Medicinal product reference set (foundation metadata concept) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4351121000168111 <p>Terminology to describe in the health record the abstract representation of an active ingredient or substance (devoid of strength and form).</p><p>The <em>Medicinal product reference set</em> supports &quot;generic prescribing&quot; in a healthcare setting.</p><p>This reference set supports the accurate and unambiguous electronic communication and exchange of medicines information between clinicians for medication management and the recording of adverse reactions.</p><p><b>Target client: </b>NCTS</p> en Definition Active Case sensitive Australian Medicines Terminology module


2608 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Medicinal product reference set Has licence SNOMED CT-AU licence​ true Inferred relationship Some 1123469472
Medicinal product reference set Developed by Australian Digital Health Agency true Inferred relationship Some 1872429997
Medicinal product reference set Is a Simple type reference set true Inferred relationship Some

Members
milnacipran
milrinone
miltefosine
mineral mixture
minocycline
minoxidil
mirabegron
mirtazapine
misoprostol
mitomycin
mitozantrone
mivacurium
mobocertinib
moclobemide
modafinil
modified long chain amylopectin
monkeypox live replication deficient vaccine
mogamulizumab
molnupiravir
mometasone
olopatadine + mometasone
monobasic potassium phosphate
montelukast
moroctocog alfa
morphine
moxifloxacin
moxonidine
mupirocin
muromonab-CD3
mycophenolate
nabiximols
nadolol
nadroparin
nafarelin
naloxegol
naloxone
oxycodone + naloxone
naltrexone
nandrolone decanoate
nanoparticle albumin-bound paclitaxel
naphazoline
naphazoline + pheniramine
naproxen
naratriptan
natalizumab
natamycin
nebivolol
nedocromil
nelfinavir
neomycin sulfate
neostigmine
nepafenac
neratinib
netupitant + palonosetron
nevirapine
nicardipine
nonivamide + nicoboxil
nicorandil
nicotinamide
nicotine
nicotinic acid
nifedipine
nilotinib
nilutamide
nimodipine
nintedanib
niraparib
nirmatrelvir
nitazoxanide
nitisinone
nitrazepam
nitric oxide
nitrofurantoin
nitroprusside
nitrous oxide
nitrous oxide + oxygen
nivolumab
nizatidine
nonacog alfa
nonacog beta pegol
nonacog gamma
nonoxinol-9
noradrenaline (norepinephrine)
norethisterone
norfloxacin
normal immunoglobulin
nortriptyline
nusinersen
nystatin
obeticholic acid
obinutuzumab
ocrelizumab
ocriplasmin
octocog alfa
octreotide
octyl methoxycinnamate + oxybenzone
octyl methoxycinnamate + oxybenzone + titanium
oestrone sulfate sodium
ofatumumab
ofloxacin
olanzapine

Start Previous Page 20 of 27 Next End


Reference Sets

Reference set descriptor

Back to Start